| Cureveda Visited by Maryland Governor Martin O'Malley |
|
Early Stage Bio-Tech Company Cited As Example Of Positive Economic Change in Maryland Life Sciences Sector |
Baltimore, MD (April 14, 2011) - Maryland Governor Martin O'Malley joined Baltimore Mayor Stephanie Rawlings-Blake, other Maryland and Baltimore City elected and appointed officials and emerging life sciences companies, including Cureveda, for the release of the Maryland Economic Development Commission (MEDC)'s 5-year strategic economic development plan.
This new plan positions Maryland for growth by building on its leading economic drivers. Life Sciences is one of the state's most important focuses.
"We are thrilled that O'Malley considers us to be an example of positive economic change. We are working hard to develop treatments for respiratory diseases with the support of GlaxoSmithKline and are excited about the talent pool and resources available to us here in this market to help us meet our business objectives, " said Cureveda CEO, Christy Wyskiel. "We look forward to even greater success and growth in the coming years."
About Cureveda LLC
Cureveda was co-founded in 2010 by Johns Hopkins Bloomberg School of Public Health faculty members Shyam Biswal and Rajesh Thimmulappa and by Christy Wyskiel. For further information, please visit the Cureveda website at www.cureveda.com.
